5.4.1 Consolidated statement of income
(in millions of euros) | Notes | 2014 | 2013 restated(7) |
---|---|---|---|
Sales | 4.1 | ||
Cost of sales | 4.3 | ( |
( |
GROSS MARGIN | 4.3 | ||
% of sales | 17.3% |
17.2% |
|
Research and Development expenditure, net | 4.51 | ( |
( |
Selling expenses | ( |
( |
|
Administrative expenses | ( |
( |
|
Operating margin | |||
% of sales | 6.8% |
6.6% |
|
Share in net earnings of equity-accounted companies | 4.5 3.1 | ||
Operating margin including share in net earnings of equity-accounted companies |
4.5 |
![XBRL logo](https://www.xbrl.org/wp-content/themes/xbrl/images/logoHeader.png)
These samples have been prepared by XBRL International as a technology demonstration, and the accuracy of figures and information contained within this sample should not be relied upon for any purpose whatsoever.